Nicolas Mach

8.1k citations
96 papers · 3.1k · 1 hit paper · h-index 25

Impact in

  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Mast cells and histamine
    • Head and Neck Cancer Studies

Papers in

Nicolas Mach

93 papers receiving 3.1k citations

Hit Papers

Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors 2021 · 257 citations
2570+1+3Years since publication50100150200250

Peers

Nicolas Mach
Comparison fields: 5 of 122
  • Immunology 1.6k
  • Otorhinolaryngology 205
  • Oncology 1.2k
  • Immunology and Allergy 175
  • Infectious Diseases 297
Replace Jasper J. Quak with:
Jasper J. Quak Netherlands
Kazunaga Agematsu Japan
Vincent R. Bonagura United States
Mélissa Dullaers Belgium
Sylvie Euvrard France
Bruce Allen Bach United States
Wendy I. White United States
Lukas Flatz Switzerland
Kenzo Takada Japan
Margaret M. Madeleine United States
Nicolas Mach relative to Jasper J. Quak Netherlands Jasper J. Quak's profile →
Citations per field
00.5×6.8×
Jasper J. Quak · 1×
Citations per year

Countries citing papers authored by Nicolas Mach

Since Specialization
Citations

This map shows the geographic impact of Nicolas Mach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Mach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Mach more than expected).

Fields of papers citing papers by Nicolas Mach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Mach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Mach. The network helps show where Nicolas Mach may publish in the future.

Co-authors

The 25 scholars most cited alongside Nicolas Mach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolas Mach Line = papers co-authored together Nicolas Mach links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998446
2
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
2000348
3
Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors
Hit paper breakdown →
2021257
4 2007195
5 2021137
6 199096
7 201493
8 200093
9 200584
10 200384
11 202083
12 200375
13
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
200173
14 201760
15 199860
16 201458
17 201756
18 200835
19 200235
20 200734

About Nicolas Mach

Nicolas Mach is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Molecular Biology and Surgery, having authored 96 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Immunotherapy and Immune Responses (22 papers), CAR-T cell therapy research (19 papers), Lung Cancer Treatments and Mutations (15 papers), Head and Neck Cancer Studies (13 papers), Cancer Research and Treatments (9 papers), Immune Cell Function and Interaction (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Immunology (1.6k citations), Otorhinolaryngology (205 citations), Oncology (1.2k citations), Immunology and Allergy (175 citations) and Infectious Diseases (297 citations). Nicolas Mach has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Glenn Dranoff, Silke Gillessen, Martín C. Mihm, S. Brian Wilson, C. Sheehan, Richard C. Mulligan, Chris S. Lantz, Stephen J. Galli, Yukifumi Nawa and Chang Ho Song. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Blood, European Journal of Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact